- Ownership
- Activity
VRX Stock Ownership Activity
VALEANT PHARMACEUTICALS INTL 13F holders
No value investing guru has made any change to the VALEANT PHARMACEUTICALS INTL (VRX) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying VRX now?
According to the latest SEC filing(s) VALEANT PHARMACEUTICALS INTL (VRX) has not been purchased by any super investor.
To see more about who is investing in VALEANT PHARMACEUTICALS INTL (VRX), please go to the VRX ownership page.
2018 Q3
(3 results)
AVG reported price*: $23.24
2018 Q2
(1 result)
Reported price*: $23.24
2018 Q1
(1 result)
Reported price*: $15.92
2017 Q4
(2 results)
AVG reported price*: $20.78
2017 Q3
(2 results)
AVG reported price*: $14.33
2017 Q1
(1 result)
Reported price*: $14.52
2016 Q4
(2 results)
AVG reported price*: $14.51
2016 Q3
(1 result)
Reported price*: $24.56
2016 Q2
(3 results)
AVG reported price*: $20.13
2016 Q1
(5 results)
AVG reported price*: $26.30
2015 Q4
(3 results)
AVG reported price*: $101.65
2015 Q3
(2 results)
AVG reported price*: $178.38
2015 Q2
(6 results)
AVG reported price*: $222.15
2015 Q1
(5 results)
AVG reported price*: $198.62
2014 Q4
(6 results)
AVG reported price*: $143.11
2014 Q3
(1 result)
Reported price*: $131.20
2014 Q2
(1 result)
Reported price*: $131.83
2014 Q1
(3 results)
AVG reported price*: $131.83
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.